Line Holten Reimer

Line Holten Reimer

Chief Investment Officer at GUBRA A/S
Health Technology
Consumer Services
Finance

Profile

Line Holten Reimer currently works at Rehfeld Medical ApS, as Director from 2017 and Gubra A, as Chief Investment Officer from 2026.
Ms. Reimer also formerly worked at Alkalon A, as Director, Medbroker ApS, as Director, Reapplix A, as Director, Aros Pharma ApS, as Director, MinervaX ApS, as Director, MedicoSelskabet September 2014 ApS, as Director, Oracain ApS, as Director, TagAway Devices ApS, as Director, Dep-Xplora ApS, as Director, and SEED Capital Management I, as Investment Manager from 2003 to 2014.
Ms. Reimer received her graduate degree from the University of Vienna and graduate degree from the University of Copenhagen.

Line Holten Reimer active positions

CompaniesPositionStart
GUBRA A/S Chief Investment Officer 01/01/2026
Director/Board Member 01/10/2017

Former positions of Line Holten Reimer

CompaniesPositionEnd
Private Equity Investor 31/12/2014
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
See the detail of Line Holten Reimer's experience

Training of Line Holten Reimer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

41

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Line Holten Reimer